Connect with us

National

Trans women in state prisons on being targeted by Trump

Uncloseted Media spoke with five incarcerated trans women in state prisons

Published

on

(Design by Sophie Holland)

Uncloseted Media published this article on Dec. 3.

Editor’s Note: This article includes references to topics such as rape, sexual assault, and violence. Reader discretion is advised.

By HOPE PISONI | Being a transgender woman in prison has always been hard for Lexie Handlang. At 38 years old, she’s a writer for the Prison Journalism Project and is currently working on a kids’ fantasy book starring a young trans girl and her friend who encounter a mysterious magical being.

Handlang has been incarcerated in men’s prisons in Missouri for 11 years, where she says she’s experienced a great deal of violence and discrimination.

She says her fears today are at an all-time high. After Trump passed an executive order on his first day in office that rolled back a suite of the scant and hard-won rights of trans women in federal prisons, Handlang remembers prison staff gleefully gloating.

“Transgenders don’t exist no more.”

“It’s not a thing.”

“I’m not gonna call you by your preferred pronouns.”

“I’m gonna call you ‘sir.’”

The executive order, titled “Defending Women from Gender Ideology Extremism and Restoring Biological Truth to the Federal Government,” includes a mandate requiring trans women to be housed in men’s prisons and a ban on the use of federal funds for gender-affirming care.

The following month, the Bureau of Prisons issued a memo banning gender-affirming items like chest binders and undergarments and requiring staff to refer to incarcerated people by their “legal name or pronouns corresponding to their biological sex.”

While the order does not apply to state prison systems, Uncloseted Media spoke with five trans women incarcerated in three different states who say Trump’s crackdown has created a trickle-down effect. They say it has produced a climate where staff are ramping up their mistreatment of trans women, federal grants for prisons are at risk as the Trump administration feuds with states, and anti-trans propaganda is turning fellow prisoners against them.

“There’s a lot of wardens who’ve been waiting for this — the discrimination has increased and it’s not anything new,” says Kenna Barnes, advocacy manager at Black and Pink, a nonprofit focused on prison abolition and the rights of incarcerated trans people. “It’s happening in every faction of the carceral system, and they are getting very emboldened, and this is a cue for them.”

Escalating attacks

Even though the Trump administration can’t force anti-trans policies on state prisons, they have still been pushing for them. In April, the Department of Justice pulled $1.4 million in funds from Maine’s Department of Corrections, the bulk of which had been allocated to support a substance use treatment program for all incarcerated people. The funding was pulled in retaliation for continuing to allow a trans woman, Andrea Balcer, to be housed in the women’s section of the Maine Correctional Center.

“You asked my feelings on being in the center of this feud between Trump and Maine — I am not in the center, I am underneath the feet of these two giants colliding, a mecha and a kaiju if you will,” Balcer, 24, told Uncloseted Media in a phone interview from the prison. “So I am not so much the center as I am collateral damage.”

Balcer was transferred to the women’s section of the prison in November 2023 due to concerns about her safety in men’s prisons, which are notoriously dangerous for trans women.

She spends much of her time playing Pathfinder, a role-playing game based on Dungeons & Dragons, and has been trying to start a group to host discussions on paganism and monthly full-moon rituals.

Balcer says she tries to keep a low profile and was getting along fairly well with her fellow prisoners after a period of adjustment.

But that changed when Attorney General Pam Bondi bullied her on Fox and Friends by calling her a “giant, 6-foot-1, 245-pound guy” and claimed that funding cuts “will protect women in prisons.” Balcer says some women at the facility turned on her and started to parrot Bondi’s rhetoric about a “man in a woman’s prison.”

“The cultural backlash has been astounding,” she says. “And it’s not that I don’t understand these women — I 100 percent understand their position. Things that have helped them and things that have done so many good things for them are being taken away, and they’re angry, as they have every right to be. But they can’t take out their anger on the people who quite frankly deserve it, [so] they take out their anger on the people that are the indirect cause of this.”

While Balcer says things have slightly improved since Maine successfully appealed the funding cuts, life is still much harder under Trump 2.0.

And she’s not the only trans woman who has a target on her back. Michelle Kailani Calvin was housed at the Central California Women’s Facility since the state’s Transgender Respect, Agency and Dignity Act — which she advocated for — passed in 2021. The act allowed trans women to be housed in women’s facilities.

Calvin, 54, was one of several trans women whose photos were included in a consequential advertisement for Trump’s 2024 campaign, which criticized Kamala Harris for supporting gender-affirming surgery in California prisons and included the infamous slogan “Kamala’s for they/them, not you.”

Difficulty accessing gender-affirming care

While gender-affirming surgeries in prison are still legally accessible in California, Calvin told Uncloseted Media via a phone call from CCWF that she has found it “very difficult … to get any kind of care” since Trump’s reelection.

She says she was scheduled for facial feminization surgery and a revision to her bottom surgery earlier this year to address complications including pain, bladder leakage and intense bleeding. Staff kept delaying them, however, claiming that she hadn’t passed a psychiatric evaluation and that she had a “dirty” toxicology report. According to Calvin, the substance that had been flagged was prescription gabapentin.

Calvin believes this foot-dragging is due to the Trump administration’s threats to cut funding, as they did with Maine.

“This is the game that the institution plays. Instead of just saying, ‘We’re not giving you a surgery because Trump ain’t giving us our money,’” she says.

Emboldened staff

Beyond having limited access to health care, Calvin says trans women face emboldened staff in Trump’s new America. In her case, this has involved increased scrutiny: After three years of no rule violations, she says she was hit with five in the span of four months.

She says several of those cases were provoked by abuse from guards. In one instance, which was documented in a report reviewed by Uncloseted Media, a guard forcefully removed her from her wheelchair and slammed her on the ground after he squeezed her shoulder without consent. She was later written up for resisting an officer.

And in March, the prison began investigating Calvin on allegations that she had assaulted her partner, who is also incarcerated. This led the prison to file a case with the California Department of Corrections and Rehabilitation’s Departmental Review Board to have her moved to a men’s prison.

Calvin says that numerous advocacy groups then sent letters to CDCR calling on them to reject the push. One lawyer, Jen Orthwein, wrote that “claims made against Ms. Calvin were submitted long after the alleged event by unnamed confidential informants, with no supporting documentation or medical evidence” and that the alleged victim “has indicated that the accusations are entirely false.” Uncloseted Media also spoke with the alleged victim from the prison where she is housed, and she affirmed that “Michelle never hurt me or any other female.”

“[The prison] feels like the Trump administration’s gonna have their back on whatever that they do, so they’re taking more bolder chances to isolate us or send us back to a men’s facility,” says Calvin.

While Calvin is still at a women’s facility, not everyone has been so lucky. CDCR recently proposed new guidelines that explicitly create a process for trans women to be transferred back to men’s prisons if they have “two or more serious Rules Violation Reports within a 12-month period.” Kelli Blackwell, 58, told Uncloseted Media on a phone call from CCWF that at least three trans women have been transferred to men’s prisons since 2024, which we confirmed on the California Incarcerated Records and Information Search website.

Blackwell is hopeful she’ll get released soon. With that in mind, she got her dentistry license and is set to earn a degree in sociology next spring. She also has a partner living with her in the women’s facility. But with increased scrutiny from CDCR and pressure from the Trump administration, she fears that a transfer to a men’s prison could disrupt all of that.

“You have trans women here that’s actually had the surgery, had the vaginoplasty — they’re still finding ways to send them back to a men’s prison,” she says.

In an email, CDCR said that they are “committed to providing a safe, humane, respectful and rehabilitative environment for all incarcerated people.” They also noted that the department “has a detailed process for patients seeking gender-affirming care, including hormonal treatment.”

Support systems have become ‘useless’

Trans women in prison are also losing the little support they had. Patricia Trimble, a 66-year-old trans woman, writer and advocate, has been incarcerated in men’s facilities in Missouri since 1979. While in prison, she’s pursued paralegal studies at Platt Junior College, theology at St. Louis University and business at Central Methodist University.

She’s used her education to advocate for herself, often through the Transgender Committee, a group of staff members required by law at each Missouri prison. The committee is meant to help the prison “make informed recommendations regarding the health and safety of transgender and intersex offenders.”

However, Trimble says that since the start of the year, the committee has become “absolutely useless.”

“At one point in time, I could sit down with the Transgender Committee … and we would discuss things that make the prison safer, and they were receptive,” Trimble told Uncloseted Media on a phone call from the Southeast Correctional Center.

“Since Trump, there are no conversations like that. When I go to the Transgender Committee, the deputy warden just kinda looks at me with that smile on her face like ‘you ain’t gettin’ nothing here, and I already know what you’re gonna ask, so let’s just go through the motions and then you can go away.’”

Trimble says this makes every issue harder to fight. In a recent incident, she tried to get transferred after being housed with a transphobic cellmate who would “bully” and “constantly pick on” her.

Trimble says that even though there were empty cells in her wing, she was sent back and forth between the Transgender Committee, case workers and her unit manager before getting approved to move into one of them. While she had the know-how to stand up for herself, most people don’t.

Even with her experience in advocacy, she says staff have been harder than usual on her. Earlier this year, after advocating for gender-affirming surgery, she says the prison put her on a call with a doctor who said she “will not be filing a report recommending any further treatment.”

“She had the audacity to tell me that she finds that I no longer suffer from gender dysphoria,” Trimble says. “And I just kinda laughed and said, ‘Okay, I guess we’re done here,’ and I got up and left.”

In an email, the Missouri Department of Corrections wrote that they do not “tolerate unprofessional conduct by staff,” and that “no changes [have been] made to policies pertaining to transgender residents of Missouri state prisons after the 2024 election.”

The danger of men’s prisons

While life in the women’s facilities is far from perfect, the people we spoke with say it’s worth fighting to stay.

According to a 2016 analysis by the Williams Institute at UCLA, 37 percent of incarcerated trans people — the overwhelming majority of whom are housed in prisons that do not match their gender identity — had experienced sexual assault within a one-year period, compared to just over 3 percent of cis people.

Blackwell says physical violence at the men’s prison, often spurred by gang activity, is “structured” and “can get you killed.” Calvin says she was raped multiple times at the men’s prison, and Trimble recounted numerous instances when guards strip-searched her in the presence of men.

Handlang says she’s experienced extreme abuse by guards at the men’s prison: “They went in my cell and they were ripping up pictures of family, trying to get me to react, ripping up my clothes, ripping up my bras, ripping up panties, destroying my makeup.” When she tried to fight back, she says “they went off camera and they broke my ankle and my foot and stomped on me and punched on me.”

As threats continue to escalate, and Trump’s policies continue to trickle down, Trimble fears she could lose the few rights she has left.

“I know that all it would take is a phone call from Trump or one of Trump’s surrogates to the governor, and the governor simply signs an executive order and everything we’ve got is taken away and we would end up having to go to court again,” she says. “If the governor wanted to, he could make our lives a lot worse with just a stroke of the pen.”

Fighting back

In the face of all these horrors, these women are advocating for themselves and caring for their trans sisters.

Handlang says that this often involves the most basic gestures: listening to their troubles, teaching them how to do their makeup and helping them buy hygiene products.

Calvin and Blackwell are still working to defend and uphold the trans-inclusive bills they helped pass, and Trimble has used her years of experience to work with legal advocacy groups to get support for things like name changes and to pressure the state to address mistreatment.

“If you’re going to be an advocate or an activist … it can never be about you,” Trimble says. “It’s about our boys and girls that are suffering in this oppressive system.”

Advertisement
FUND LGBTQ JOURNALISM
SIGN UP FOR E-BLAST

Israel

A Wider Bridge to close

LGBTQ Jewish group said financial challenges prompted decision

Published

on

U.S. Rep. Debbie Wasserman Schultz (D-Fla.) speaks at the Capital Jewish Museum in D.C. on June 5, 2025, after A Wider Bridge honored her at its Pride event. A Wider Bridge has announced it will shut down. (Washington Blade photo by Michael K. Lavers)

A Wider Bridge on Friday announced it will shut down at the end of the month.

The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.

“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.

“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”

Arthur Slepian founded A Wider Bridge in 2010.

The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.

A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.  

The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.

A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.

“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”

Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.

Continue Reading

The White House

‘Trump Rx’ plan includes sharp cuts to HIV drug prices

President made announcement on Friday

Published

on

President Donald Trump during his meeting on lowering drug prices through TrumpRx. (Washington Blade photo by Joe Reberkenny)

President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.

During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.

“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”

Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”

“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.

Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.

Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.

Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.

Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.

These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”

Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.

“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”

Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.

“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.

“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.

Trump interjected, asking, “And that’s working well with HIV?”

“Yes,” O’Day replied.

“It’s a big event,” Trump said.

“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.

A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.

Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.

According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.

The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.

Continue Reading

The White House

EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine

Trans former assistant health secretary’s name changed on official portrait

Published

on

Adm. Rachel Levine (Washington Blade photo by Michael Key)

Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.

The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.

Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.

According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.

Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.

“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.

“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”

“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”

The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.

The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.

The Washington Blade reached out to HHS, but has not received any comment.

The lawsuit and four FOIA requests are below:

Continue Reading

Popular